Question: Payne Medical Labs is evaluating two new products to introduce into the marketplace. Product 1 (a new form of plaster cast) is relatively low in risk for this business and will carry a 10 percent discount rate. Product 2 (a knee joint support brace) has a less predictable outcome and will require a higher discount rate of 15 percent. Either investment will require an initial capital outlay of $90,000. The inflows from projected business over the next five years are given below. Which product should be selected, using net present value analysis?
